The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

You wanted to know about my ALT and other report
Aug 6, 2012

Many many thanks and appriciate for answering me. here is my whole Analysis report. APL 79 (range 45-129). ALT 45 (up to 35). AST 31 (up to 38). yGT 35 (10-66). T.Bilirubin 0.24 mg/dl. Bilirubin Direct 0.09 mg/dl. Indirect Bilirubin 0.15 mg/dl. protein total 7.80 g/dl. Albumin 4.80 g/dl. Globulin 3.00 g/dl. Globulin 129 U/l (range 135-225). HBV-DNA viral load: 200,000 iu/ml. HBsAg ll(6256 positive index): Anti-HCV( 0.26 negative col.), Anti-HBs (<2,00 mlu/ml); Anti-HBc (lgG+lgM) (0.009 positive s/co). HBeAg:(negative). Anti-HBe :( positive). Anti-HBc lgM : (negative)

Response from Dr. McGovern

I don't know which former question this applies to but it appears on your HBV panel that you have HBe antigen negative infection with a lower viral load than what we see in HBe antigen positive infection. That is good news if you need treatment, since most drugs will easily suppress your virus from this point.

Your ALT is just a bit elevated so I would probably continue to monitor you to see what happens over time before starting therapy.

So Truvada shows no HBV restitance

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint